Cutaneous Melanoma Detection and Management
Cutaneous Melanoma Detection and Management is a research topic within Oncology. Science Explorer counts 37k research works in it since 1950. 12.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and epidemiology of melanoma, a type of skin cancer. It covers topics such as dermatologist-level classification, genetic alterations, sentinel lymph node biopsy, immunotherapy, tumor staging, deep learning for melanoma recognition, and survival analysis. The papers also discuss the epidemiological trends and risk factors associated with melanoma.
- Melanoma
- Dermoscopy
- Skin Cancer
- Sentinel Lymph Node Biopsy
- Genetic Alterations
- Immunotherapy
- Tumor Staging
- Deep Learning
- Survival Analysis
- Epidemiology
- Research works
- 37k fractional, since 1950
- In the world top 10%
- 4.5k per year above
- Top-10% rate
- 12.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +50% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cutaneous Melanoma Detection and Management research?
By volume, the United States and India publish the most (2.2k and 1.3k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 India 1.3k works
- 3 China 795 works
- 4 United Kingdom 417 works
- 5 Italy 349 works
- 6 Germany 335 works
- 7 Australia 292 works
- 8 Spain 249 works
- 9 France 212 works
- 10 Japan 172 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cutaneous Melanoma Detection and Management research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Cutaneous Melanoma Detection and Management research, followed by SRM Institute of Science and Technology and Saveetha University.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 42 works
- 2 SRM Institute of Science and TechnologyIndia 42 works
- 3 Saveetha UniversityIndia 41 works
- 4 Chandigarh UniversityIndia 39 works
- 5 Chitkara UniversityIndia 38 works
- 6 The University of Texas MD Anderson Cancer CenterUnited States 37 works
- 7 Vellore Institute of Technology UniversityIndia 34 works
- 8 The University of QueenslandAustralia 33 works
- 9 Harvard UniversityUnited States 33 works
- 10 The University of SydneyAustralia 30 works
Who are the leading researchers in Cutaneous Melanoma Detection and Management?
The most-cited researchers publishing on Cutaneous Melanoma Detection and Management include Luigi Naldi and Dirk Schadendorf.
- 1 Luigi Naldi Italy 4.7k citations
- 2 Dirk Schadendorf Germany 4.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cutaneous Melanoma Detection and Management research done?
The largest centres of Cutaneous Melanoma Detection and Management research in 2022–2025 are Chennai (India), New York (United States), London (United Kingdom) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Omaha, Mohali and Vijayawada.
Largest cities, 2022–2025
- 1 Chennai India 187 works
- 2 New York United States 139 works
- 3 London United Kingdom 113 works
- 4 Beijing China 104 works
- 5 Sydney Australia 101 works
- 6 Boston United States 84 works
- 7 Philadelphia United States 83 works
- 8 Shanghai China 78 works
- 9 Brisbane Australia 67 works
- 10 Dhaka Bangladesh 65 works
Where it is the local speciality
- OmahaUS · 31.2 works7.2×
- MohaliIN · 39.6 works6.7×
- VijayawadaIN · 27.1 works6.6×
Location quotient: how much more of its research is in Cutaneous Melanoma Detection and Management than the world average.
Where is the best place to study Cutaneous Melanoma Detection and Management?
Among universities, judged by research, Chitkara University, Jawaharlal Nehru Technological University, Hyderabad and Chandigarh University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chitkara UniversityIndia | 65.0 | 14.3% | 11.1× | 38 | — |
| 2 | Jawaharlal Nehru Technological University, HyderabadIndia | 61.6 | 31.6% | 9.4× | 9 | — |
| 3 | Chandigarh UniversityIndia | 59.5 | 14.7% | 7.9× | 39 | — |
| 4 | Carol Davila University of Medicine and PharmacyRomania | 54.3 | 23.4% | 7.3× | 10 | +113.3% |
| 5 | Vellore Institute of Technology UniversityIndia | 51.8 | 19.7% | 3.9× | 34 | — |
| 6 | The University of QueenslandAustralia | 49.9 | 14.5% | 4.6× | 33 | +15.5% |
| 7 | Saveetha UniversityIndia | 48.8 | 10.1% | 4.8× | 41 | — |
| 8 | Amity UniversityIndia | 48.7 | 30.2% | 4.1× | 10 | — |
| 9 | SRM Institute of Science and TechnologyIndia | 48.6 | 9.3% | 5.6× | 42 | — |
| 10 | Kalasalingam Academy of Research and EducationIndia | 48.2 | 19.1% | 7.9× | 11 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cutaneous Melanoma Detection and Management research growing?
Output in 2018–2022 was 50% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cutaneous Melanoma Detection and Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.